MEDICAL RESOURCES

M7824 bifunctional immunotherapy

Status

• M7824 (also known as MSB0011359C) is an investigational, bifunctional immunotherapy designed to simultaneously block PD-L1 and TGF-β, two immuno-inhibitory pathways that are commonly used by cancer cells to evade the immune system

Action SVG
Action SVG
Action SVG
eMedI Chat
Close
After your vist, Please answer a few questions to help us improve?
Survey
Please click on icon to provide survey...